1.Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Overview and Summary 2024
Young Joo PARK ; Eun Kyung LEE ; Young Shin SONG ; Bon Seok KOO ; Hyungju KWON ; Keunyoung KIM ; Mijin KIM ; Bo Hyun KIM ; Won Gu KIM ; Won Bae KIM ; Won Woong KIM ; Jung-Han KIM ; Hee Kyung KIM ; Hee Young NA ; Shin Je MOON ; Jung-Eun MOON ; Sohyun PARK ; Jun-Ook PARK ; Ji-In BANG ; Kyorim BACK ; Youngduk SEO ; Dong Yeob SHIN ; Su-Jin SHIN ; Hwa Young AHN ; So Won OH ; Seung Hoon WOO ; Ho-Ryun WON ; Chang Hwan RYU ; Jee Hee YOON ; Ka Hee YI ; Min Kyoung LEE ; Sang-Woo LEE ; Seung Eun LEE ; Sihoon LEE ; Young Ah LEE ; Joon-Hyop LEE ; Ji Ye LEE ; Jieun LEE ; Cho Rok LEE ; Dong-Jun LIM ; Jae-Yol LIM ; Yun Kyung JEON ; Kyong Yeun JUNG ; Ari CHONG ; Yun Jae CHUNG ; Chan Kwon JUNG ; Kwanhoon JO ; Yoon Young CHO ; A Ram HONG ; Chae Moon HONG ; Ho-Cheol KANG ; Sun Wook KIM ; Woong Youn CHUNG ; Do Joon PARK ; Dong Gyu NA ;
International Journal of Thyroidology 2024;17(1):1-20
Differentiated thyroid cancer demonstrates a wide range of clinical presentations, from very indolent cases to those with an aggressive prognosis. Therefore, diagnosing and treating each cancer appropriately based on its risk status is important. The Korean Thyroid Association (KTA) has provided and amended the clinical guidelines for thyroid cancer management since 2007. The main changes in this revised 2024 guideline include 1) individualization of surgical extent according to pathological tests and clinical findings, 2) application of active surveillance in low-risk papillary thyroid microcarcinoma, 3) indications for minimally invasive surgery, 4) adoption of World Health Organization pathological diagnostic criteria and definition of terminology in Korean, 5) update on literature evidence of recurrence risk for initial risk stratification, 6) addition of the role of molecular testing, 7) addition of definition of initial risk stratification and targeting thyroid stimulating hormone (TSH) concentrations according to ongoing risk stratification (ORS), 8) addition of treatment of perioperative hypoparathyroidism, 9) update on systemic chemotherapy, and 10) addition of treatment for pediatric patients with thyroid cancer.
2.Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
Hundo CHO ; Jin-Hyuk CHOI ; Seok Yun KANG ; Hyun Woo LEE ; Yong Won CHOI ; Tae-Hwan KIM ; Mi Sun AHN ; Chul-Ho KIM ; Yoo Seob SHIN ; Jeon Yeob JANG ; Young-Taek OH ; Jaesung HEO ; Seung Soo SHEEN
The Korean Journal of Internal Medicine 2022;37(3):653-659
Background/Aims:
The study investigated the incidence of thromboembolic events (TEE) in head and neck (H&N) cancer patients who received concurrent chemoradiotherapy (CCRT) with cisplatin, and analyzed the factors affecting TEE occurrence
Methods:
Two hundred and fifty-seven patients who started CCRT with cisplatin for H&N cancer from January 2005 to December 2019 were analyzed.
Results:
TEE occurred in five patients, an incidence rate of 1.9%. The 2-, 4-, and 6-month cumulative incidences of TEE were 0.8%, 1.6%, and 1.9%, respectively. Khorana score was the only factor associated with TEE occurrence (p = 0.010).
Conclusions
The incidence of TEE in H&N cancer patients who underwent CCRT with cisplatin was relatively low when compared to other types of cancer. However, patients with a high Khorana score require more careful surveillance for possible TEE occurrence.
3.Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
Hundo CHO ; Jin-Hyuk CHOI ; Seok Yun KANG ; Hyun Woo LEE ; Yong Won CHOI ; Tae-Hwan KIM ; Mi Sun AHN ; Chul-Ho KIM ; Yoo Seob SHIN ; Jeon Yeob JANG ; Young-Taek OH ; Jaesung HEO ; Seung Soo SHEEN
The Korean Journal of Internal Medicine 2022;37(6):1269-
4.The First Korean Case of NUP98-NSD1 and a Novel SNRK-ETV6 Fusion in a Pediatric Therapy-related Acute Myeloid Leukemia Patient Detected by Targeted RNA Sequencing
Ha Jin LIM ; Jun Hyung LEE ; Young Eun LEE ; Hee-Jo BAEK ; Hoon KOOK ; Ju Heon PARK ; Seung Yeob LEE ; Hyun-Woo CHOI ; Hyun-Jung CHOI ; Seung-Jung KEE ; Jong Hee SHIN ; Myung Geun SHIN
Annals of Laboratory Medicine 2021;41(4):443-446
5.Performance Evaluation of VITEK MS for the Identification of a Wide Spectrum of Clinically Relevant Filamentous Fungi Using a Korean Collection
Ju Hyeon SHIN ; Soo Hyun KIM ; Dain LEE ; Seung Yeob LEE ; Sejong CHUN ; Jun Hyung LEE ; Eun Jeong WON ; Hyun Jung CHOI ; Hyun Woo CHOI ; Seung Jung KEE ; Myung Geun SHIN ; Jong Hee SHIN
Annals of Laboratory Medicine 2021;41(2):214-220
The correct identification of filamentous fungi is challenging. We evaluated the performance of the VITEK MS v3.0 system (bioMérieux, Marcy-l’Étoile, France) for the identification of a wide spectrum of clinically relevant filamentous fungi using a Korean collection. Strains that were added to the upgraded v3.2 database were additionally identified by the VITEK MS v3.2 system. Of the 105 tested isolates, including 37 Aspergillus (nine species), 41 dermatophytes (seven species), and 27 other molds (17 species), 43 (41.0%) showed “no identification” or “multiple species identification” results at the initial VITEK MS testing; these isolates were retested using the same method. Compared with sequence-based identification, the correct identification rate using VITEK MS for Aspergillus, dermatophytes, other molds, and total mold isolates was 67.6%, 56.1%, 48.1%, and 58.1% at the initial testing and 94.6%, 78.0%, 55.6%, and 78.1% with retesting, respectively. Following retesting, 19 (18.1%) and two (1.9%) isolates showed “no identification” and “misidentification” results, respectively. VITEK MS reliably identified various filamentous fungi recovered in Korea, with a very low rate of misidentification
6.Functional Reconstruction of the Digit using Palmaris Longus Tendocutaneous Arterialized Venous Free Flap.
Young Kun LEE ; Joo Yong KIM ; Seung Yeob SAGONG ; Young Woo KIM ; Sang Hyun WOO
Journal of the Korean Society for Surgery of the Hand 2014;19(3):136-144
PURPOSE: The purpose of this study was to present the results after functional reconstruction of the digits using palmaris longus tendocutaneous arterialized venous free flap in digits with compound defects. METHODS: This study is based on 29 cases of palmaris longus tendocutaneous arterialized venous free flaps harvested from the ipsilateral wrist for the reconstruction of compound defect of the digits. Over the past 10 years, we performed in 17 cases of complex defects of extensor tendon on dorsum of the digits, 7 cases of collateral ligament of the proximal or distal interphalangeal joint and 5 cases of flexor tendon defect with soft tissue defect on the palmar aspect of the digits. We assessed survival rate of the flaps and functional recovery of the digits. RESULTS: All free flaps completely survived except one with completele necrosis and another one with 50% necrosis. In cases of extensor tendon defect, the mean total active range of motion of the digits was 180degrees, in cases of flexor tendon reconstruction, it was 165degrees. In reconstruction of collateral ligament of interphalangeal joint of the thumb and digits, flexion and extension was within normal range and we got very good results without instability in all 7 cases. CONCLUSION: Palmaris longus tendocutaneous arterialized venous free flaps are very useful for reconstruction of composite defect of the digits with extensor or flexor tendons as well as collateral ligaments.
Collateral Ligaments
;
Free Tissue Flaps*
;
Joints
;
Necrosis
;
Range of Motion, Articular
;
Reference Values
;
Survival Rate
;
Tendons
;
Thumb
;
Wrist
7.ERRATUM: Correction for the number of the recruited patients and the participating institutions. Prospective randomized controlled trial (phase III) to comparing laparoscopic distal gastrectomy with open distal gastrectomy for gastric adenocarcinoma (KLAS.
Hyung Ho KIM ; Sang Uk HAN ; Min Chan KIM ; Woo Jin HYUNG ; Wook KIM ; Hyuk Joon LEE ; Seung Wan RYU ; GyuSeok CHO ; Chan Young KIM ; Han Kwang YANG ; Do Joong PARK ; Kyo Young SONG ; Sang Il LEE ; Seong Yeob RYU ; Joo Ho LEE
Annals of Surgical Treatment and Research 2014;87(1):51-52
We found an Fig. 1 error in our published article.
8.Prospective randomized controlled trial (phase III) to comparing laparoscopic distal gastrectomy with open distal gastrectomy for gastric adenocarcinoma (KLASS 01).
Hyung Ho KIM ; Sang Uk HAN ; Min Chan KIM ; Woo Jin HYUNG ; Wook KIM ; Hyuk Joon LEE ; Seung Wan RYU ; Gyu Seok CHO ; Chan Young KIM ; Han Kwang YANG ; Do Joong PARK ; Kyo Young SONG ; Sang Il LEE ; Seong Yeob RYU ; Joo Ho LEE
Journal of the Korean Surgical Society 2013;84(2):123-130
A randomized controlled trial to evaluate the long-term outcomes of laparoscopic distal gastrectomy for gastric cancer is currently ongoing in Korea. Patients with cT1N0M0-cT2aN0M0 (American Joint Committee on Cancer, 6th edition) distal gastric cancer were randomized to receive either laparoscopic or open distal gastrectomy. For surgical quality control, the surgeons participating in this trial had to have performed at least 50 cases each of laparoscopy-assisted distal gastrectomy and open distal gastrectomy and their institutions should have performed more than 80 cases each of both procedures each year. Fifteen surgeons from 12 institutions recruited 1,415 patients. The primary endpoint is overall survival. The secondary endpoints are disease-free survival, morbidity, mortality, quality of life, inflammatory and immune responses, and cost-effectiveness (ClinicalTrials.gov ID: NCT00452751).
Adenocarcinoma
;
Disease-Free Survival
;
Gastrectomy
;
Humans
;
Joints
;
Korea
;
Prospective Studies
;
Quality Control
;
Quality of Life
;
Stomach Neoplasms
9.Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.
Jae Young JANG ; Moon Young KIM ; Soung Won JEONG ; Tae Yeob KIM ; Seung Up KIM ; Sae Hwan LEE ; Ki Tae SUK ; Soo Young PARK ; Hyun Young WOO ; Sang Gyune KIM ; Jeong HEO ; Soon Koo BAIK ; Hong Soo KIM ; Won Young TAK
Clinical and Molecular Hepatology 2013;19(1):1-16
The application of ultrasound contrast agents (UCAs) is considered essential when evaluating focal liver lesions (FLLs) using ultrasonography (US). Microbubble UCAs are easy to use and robust; their use poses no risk of nephrotoxicity and requires no ionizing radiation. The unique features of contrast enhanced US (CEUS) are not only noninvasiveness but also real-time assessing of liver perfusion throughout the vascular phases. The later feature has led to dramatic improvement in the diagnostic accuracy of US for detection and characterization of FLLs as well as the guidance to therapeutic procedures and evaluation of response to treatment. This article describes the current consensus and guidelines for the use of UCAs for the FLLs that are commonly encountered in US. After a brief description of the bases of different CEUS techniques, contrast-enhancement patterns of different types of benign and malignant FLLs and other clinical applications are described and discussed on the basis of our experience and the literature data.
Contrast Media/chemistry/*diagnostic use
;
Humans
;
Liver Diseases/radiography/*ultrasonography
;
Liver Neoplasms/radiography/*ultrasonography
;
Phospholipids/chemistry/diagnostic use
;
Practice Guidelines as Topic
;
Sulfur Hexafluoride/chemistry/diagnostic use
;
Tomography, X-Ray Computed
10.A Case of Kerion Celsi Caused by Microsporum gypseum.
Dong Yeob KO ; Seung Min HA ; Su Young JEON ; Kwang Sook WOO ; Jin Yeong HAN ; Ki Hoon SONG ; Ki Ho KIM
Korean Journal of Dermatology 2013;51(5):375-376
No abstract available.
Microsporum
;
Tinea Capitis

Result Analysis
Print
Save
E-mail